Literature DB >> 17609971

Type I diabetic bone phenotype is location but not gender dependent.

Lindsay M Martin1, Laura R McCabe.   

Abstract

Bone is highly dynamic and responsive. Bone location, bone type and gender can influence bone responses (positive, negative or none) and magnitude. Type I diabetes induces bone loss and increased marrow adiposity in the tibia. We tested if this response exhibits gender and location dependency by examining femur, vertebrae and calvaria of male and female, control and diabetic BALB/c mice. Non-diabetic male mice exhibited larger body, muscle, and fat mass, and increased femur BMD compared to female mice, while vertebrae and calvarial bone parameters did not exhibit gender differences. Streptozotocin-induced diabetes caused a reduction in BMD at all sites examined irrespective of gender. Increased marrow adiposity was evident in diabetic femurs and calvaria (endochondrial and intramembranous formed bones, respectively), but not in vertebrae. Leptin-deficient mice also exhibit location dependent bone responses and we found that serum leptin levels were significantly lower in diabetic compared to control mice. However, in contrast to leptin-deficient mice, the vertebrae of T1-diabetic mice exhibit bone loss, not gain. Taken together, our findings indicate that TI-diabetic bone loss in mice is not gender, bone location or bone type dependent, while increased marrow adiposity is location dependent.

Entities:  

Mesh:

Year:  2007        PMID: 17609971     DOI: 10.1007/s00418-007-0308-4

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  75 in total

Review 1.  Playing with bone and fat.

Authors:  Jeffrey M Gimble; Sanjin Zvonic; Z Elizabeth Floyd; Moustapha Kassem; Mark E Nuttall
Journal:  J Cell Biochem       Date:  2006-05-15       Impact factor: 4.429

2.  Leptin predicts BMD and bone resorption in older women but not older men: the Rancho Bernardo study.

Authors:  Lauren A Weiss; Elizabeth Barrett-Connor; Denise von Mühlen; Patricia Clark
Journal:  J Bone Miner Res       Date:  2006-05       Impact factor: 6.741

3.  Bone formation is impaired in a model of type 1 diabetes.

Authors:  Kathryn M Thrailkill; Lichu Liu; Elizabeth C Wahl; Robert C Bunn; Daniel S Perrien; Gael E Cockrell; Robert A Skinner; William R Hogue; Adam A Carver; John L Fowlkes; James Aronson; Charles K Lumpkin
Journal:  Diabetes       Date:  2005-10       Impact factor: 9.461

4.  Increased bone adiposity and peroxisomal proliferator-activated receptor-gamma2 expression in type I diabetic mice.

Authors:  Sergiu Botolin; Marie-Claude Faugere; Hartmut Malluche; Michael Orth; Ron Meyer; Laura R McCabe
Journal:  Endocrinology       Date:  2005-05-19       Impact factor: 4.736

5.  Middle-aged premenopausal women with type 1 diabetes have lower bone mineral density and calcaneal quantitative ultrasound than nondiabetic women.

Authors:  Elsa S Strotmeyer; Jane A Cauley; Trevor J Orchard; Ann R Steenkiste; Janice S Dorman
Journal:  Diabetes Care       Date:  2006-02       Impact factor: 19.112

6.  Intravitreous leptin concentrations in patients with proliferative diabetic retinopathy.

Authors:  Cristina Hernández; Albert Lecube; Josep María Castellanos; Rosa María Segura; Magela Garat; José García-Arumí; Rafael Simó
Journal:  Retina       Date:  2004-02       Impact factor: 4.256

7.  Responsiveness of gene expression markers of osteoblastic and osteoclastic activity to calcitonin in the appendicular and axial skeleton of the rat in vivo.

Authors:  L G Jenis; B Ongphiphadhanakul; L E Braverman; G S Stein; J B Lian; R Lew; D T Baran
Journal:  Calcif Tissue Int       Date:  1994-06       Impact factor: 4.333

8.  The relationship among serum cytokines, chemokine, nitric oxide, and leptin in children with type 1 diabetes mellitus.

Authors:  Hui-Chen Lo; Su-Chen Lin; Yu-Mei Wang
Journal:  Clin Biochem       Date:  2004-08       Impact factor: 3.281

9.  Tetracycline administration restores osteoblast structure and function during experimental diabetes.

Authors:  T Sasaki; H Kaneko; N S Ramamurthy; L M Golub
Journal:  Anat Rec       Date:  1991-09

10.  Gender differences in the relationship between leptin, insulin resistance and the autonomic nervous system.

Authors:  Daniel E Flanagan; Julian C Vaile; Graham W Petley; David I Phillips; Ian F Godsland; Phillip Owens; Vivienne M Moore; Richard A Cockington; Jeffrey S Robinson
Journal:  Regul Pept       Date:  2006-12-21
View more
  23 in total

1.  Alteration of vitamin D metabolic enzyme expression and calcium transporter abundance in kidney involved in type 1 diabetes-induced bone loss.

Authors:  Y Zhang; C J Papasian; H-W Deng
Journal:  Osteoporos Int       Date:  2010-09-29       Impact factor: 4.507

Review 2.  Recent progress in histochemistry.

Authors:  Christian Zuber; Douglas J Taatjes; Jürgen Roth
Journal:  Histochem Cell Biol       Date:  2007-10-31       Impact factor: 4.304

Review 3.  The multiple faces of autoimmune-mediated bone loss.

Authors:  Georg Schett; Jean-Pierre David
Journal:  Nat Rev Endocrinol       Date:  2010-11-02       Impact factor: 43.330

4.  Bisphosphonate treatment of type I diabetic mice prevents early bone loss but accentuates suppression of bone formation.

Authors:  Lindsay M Coe; Srinivasan Arjun Tekalur; Yutian Shu; Melissa J Baumann; Laura R McCabe
Journal:  J Cell Physiol       Date:  2015-08       Impact factor: 6.384

Review 5.  Marrow fat and bone--new perspectives.

Authors:  Pouneh K Fazeli; Mark C Horowitz; Ormond A MacDougald; Erica L Scheller; Matthew S Rodeheffer; Clifford J Rosen; Anne Klibanski
Journal:  J Clin Endocrinol Metab       Date:  2013-02-07       Impact factor: 5.958

6.  Loss of interleukin-10 exacerbates early Type-1 diabetes-induced bone loss.

Authors:  Naiomy D Rios-Arce; Andrew Dagenais; Derrick Feenstra; Brandon Coughlin; Ho Jun Kang; Susanne Mohr; Laura R McCabe; Narayanan Parameswaran
Journal:  J Cell Physiol       Date:  2019-09-19       Impact factor: 6.384

7.  CCAAT/enhancer binding protein β-deficiency enhances type 1 diabetic bone phenotype by increasing marrow adiposity and bone resorption.

Authors:  Katherine J Motyl; Michelle Raetz; Srinivasan Arjun Tekalur; Richard C Schwartz; Laura R McCabe
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-02-23       Impact factor: 3.619

8.  Inflammatory bowel disease causes reversible suppression of osteoblast and chondrocyte function in mice.

Authors:  Laura Harris; Patricia Senagore; Vincent B Young; Laura R McCabe
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-03-19       Impact factor: 4.052

Review 9.  Marrow Adipose Tissue: Trimming the Fat.

Authors:  Erica L Scheller; William P Cawthorn; Aaron A Burr; Mark C Horowitz; Ormond A MacDougald
Journal:  Trends Endocrinol Metab       Date:  2016-04-16       Impact factor: 12.015

Review 10.  Marrow fat and the bone microenvironment: developmental, functional, and pathological implications.

Authors:  Clifford J Rosen; Cheryl Ackert-Bicknell; Juan Pablo Rodriguez; Ana Maria Pino
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2009       Impact factor: 1.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.